Evidence map›Paper›PMID 33078591›Full record

ArticleJournal of gynecologic oncology2020

Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?

Stephanie Chow, Deanna Wong, Cheng I Liao, Amandeep Mann, Chunqiao Tian, Kathleen M Darcy, John K Chan

Open access · diamondAbstract read
In one paragraph

Article in Journal of gynecologic oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Stephanie ChowDivision of Gynecologic Oncology, Stanford University Medical Center, Stanford, CA, USA. stephchow@stanford.edu.ORCID https://orcid.org/0000-0002-3307-7982
Deanna WongDepartment of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0003-4622-0511
Cheng I LiaoDepartment of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0001-5086-6871
Amandeep MannDivision of Gynecologic Oncology, Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA.ORCID https://orcid.org/0000-0002-9470-4839
Chunqiao TianGynecologic Cancer Center of Excellence, Department of Obstetrics & Gynecology, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA.ORCID https://orcid.org/0000-0003-3815-8025
Kathleen M DarcyGynecologic Cancer Center of Excellence, Department of Obstetrics & Gynecology, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA.ORCID https://orcid.org/0000-0003-2888-2968
John K ChanDivision of Gynecologic Oncology, Palo Alto Medical Foundation, California Pacific Medical Center, Sutter Health, San Francisco, CA, USA.ORCID https://orcid.org/0000-0003-3379-6829
Henry M. Jackson Foundation · USKaohsiung Veterans General Hospital · TWPalo Alto Institute · USStanford Medicine · USSutter Health · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine incidence rates of uterine clear cell carcinoma among non-White US subpopulations.

methodsData from the United States Cancer Statistics and National Cancer Database from 2004 to 2016 were analyzed using descriptive statistics.

resultsA total of 488,811 women were diagnosed with uterine cancer from 2004-2016. Of these, 73.3% were endometrioid, 6.6% were serous, 5.3% were carcinosarcoma, 1.4% were clear cell, and 13.4% were other. Blacks had the highest incidence rate of uterine clear cell compared with Whites, Asian/Pacific Islanders, and American Indian/Alaska Natives (0.59 vs. 0.31, 0.29, and 0.24, respectively). Overall mean age at diagnosis was 68.6 years, with the youngest age in Asian/Pacific Islanders compared to Whites, Blacks, and American Indian/Alaska Natives (65.9 vs. 68.7, 68.6, and 66.3 years, respectively). Analysis of the Asian subpopulation revealed significantly younger age at diagnosis in Vietnamese women (55.8 years) compared with 72.4 years in Japanese, 68.6 years in Pacific Islander, 66.6 years in Indian/Pakistani, 65.9 years in Filipino, 65.8 years in Chinese, 65.2 years in Korean, and 63.7 years in other Asians.

conclusionsBlack women are two times more likely to be diagnosed with uterine clear cell carcinoma compared with other races. Asians present at younger ages, with Vietnamese women most likely to be diagnosed at the youngest age.

Indexed as

Adenocarcinoma, Clear CellUterine NeoplasmsBlack or African AmericanEthnicityFemaleHumansIncidenceUnited StatesUterusAdenocarcinoma, Clear CellAfrican AmericansAsian AmericansEthnic GroupsIncidenceUterine Neoplasms

Identifiers

PMID33078591
PMCPMC7593224
OpenAlexW3043082463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.